breast cancer

Some cancer cells survive chemotherapy by devouring their neighboring tumor cells, research from Tulane University suggests[1]. This act of cannibalism may give these cancer cells the energy required to stay alive and begin tumor relapse after the treatment is completed. “Understanding the properties of these senescent cancer cells that allow their survival after chemotherapy treatment… Read more

A reusable breast cancer treatment device could offer a low-cost alternative for women in low-income and low-resource countries. The tissue-freezing probe uses cryoablation, a method that kills cancerous tissue by exposing it to extremely cold temperatures, and uses carbon dioxide, a widely available and affordable alternative to argon, the current industry standard. “Innovation in cancer… Read more

The enzyme Prolyl 4-hydroxylase subunit alpha-1 (P4HA1) is a potential therapeutic target for triple negative breast cancer, a study led by University of Kentucky Markey Cancer Center researchers suggests. Collagen prolyl 4-hydroxylase (P4H) expression and collagen hydroxylation in cancer cells are necessary for breast cancer progression. Performed in the lab of UK College of Medicine… Read more

The gene Sox10 directly controls the growth and invasion of a significant fraction of hard-to-treat triple-negative breast cancers, a team at the Salk Institute has found. Recently, the Salk lab led by Professor Geoffrey Wahl discovered that aggressive breast cancers return to a flexible, earlier state found in fetal breast tissue. This cellular reprogramming may… Read more